In AD, elevated N-glycosylated tau in brain tissue and CSF has been associated with advanced Braak stages and greater neurofibrillary tangle burden, reflecting a molecular shift toward aggregation-prone conformers [29,39]. This evidence concerns the gene MAPT and Alzheimer disease.